SCHEMBL4999813

SCHEMBL4999813

CCCOc1c(Br)cc(-c2nccc(-c3cc4n(n3)CCNC4=O)n2)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.41
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HTT P42858 1/20 0.34
FPR2 P25090 1/20 0.34
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
MIF P14174 1/20 0.33
LRRK2 Q5S007 3/20 0.32
PRKD3 O94806 2/20 0.31
PRKCG P05129 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4997398 0.96 CDC7 (0.40) CDC7ALDH1A1SMN1; SMN2MAPTRAB9A
SCHEMBL4996355 0.93 CDC7 (0.41) CDC7ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4991786 0.93 CDC7 (0.42) CDC7MAPTGAAMEN1KMT2A
SCHEMBL4996896 0.91 CDC7 (0.45) CDC7PIM1PIM2LRRK2PRKD3
SCHEMBL5002516 0.90 CDC7 (0.41) CDC7MAPTMEN1KMT2AFPR2
SCHEMBL4999834 0.89 CDC7 (0.40) CDC7ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL5000323 0.88 CDC7 (0.42) CDC7ALDH1A1SMN1; SMN2MAPTL3MBTL1
SCHEMBL4991902 0.88 CDC7 (0.43) CDC7ALDH1A1SMN1; SMN2MAPTL3MBTL1
SCHEMBL4997449 0.87 ALDH1A1 (0.41) CDC7ALDH1A1SMN1; SMN2GAAMEN1
SCHEMBL4996397 0.87 CDC7 (0.48) CDC7PIM1PIM2LRRK2PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS MKNK2, MAPKAPK2, MAP3K2 CDC7 487/4885ALDH1A1 4153/4885SMN1; SMN2 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.